Amsterdam-Based Amdocs Broadens Capabilities of its ESIM SaaS Platform with New Support Features

Amdocs Enhances eSIM Cloud Platform with RCS Compliance for Advanced Messaging Services JERSEY CITY, NJ – Amdocs, a pioneering software and services company for communications and media industries, is thrilled to announce a significant milestone in the telecommunications sector. In collaboration with Google, Amdocs has certified its eSIM Cloud platform for RCS (Rich Communication Services)…

Read More

Top 4 Gold Stocks to Consider as Safe-Haven Investments: Insights from Industry Experts

Gold Stocks: A Shining Opportunity Amid Inflation Fear Gold has long been considered a safe-haven asset, sought after during times of economic uncertainty and inflation. The yellow metal’s value tends to rise when the purchasing power of currency decreases. Given the current economic climate, with inflation fears on the rise, investing in gold stocks could…

Read More

Revolutionizing Investment Strategies: Introducing Model Portfolios and Defined Outcome ETFs with Our Innovative Portfolio Builder Tool

Innovator Launches Model Portfolios and Defined Outcome ETF™ Portfolio Builder… A New Era in Investment Strategy As we enter a new era of investment strategy, Innovator is leading the way with the launch of model portfolios and Defined Outcome ETF™ Portfolio Builder. This platform provides financial advisors with a comprehensive framework to construct portfolios of…

Read More

Lilly’s Ebglyss (Lebrikizumab LBKZ) Shows Significant Improvement in Skin Clearance and Itch Relief for Patients with Moderate to Severe Atopic Dermatitis After Discontinuing Dupilumab

New Treatment EBGLYSS Shows Promising Results in Patients with Atopic Dermatitis Overview In a groundbreaking study, Eli Lilly and Company’s EBGLYSS has shown significant improvements in patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. This selective IL-13 inhibitor has provided meaningful improvements in difficult-to-treat areas such as face and hand dermatitis, marking…

Read More

Westlake Chemical’s Surprising Q4 Miss: A Tale of Lagging Earnings and Revenue Estimates

Westlake Chemical’s Quarterly Earnings Misses Expectations: A Peek Behind the Scenes Westlake Chemical Corporation (WLK), a leading petrochemicals and polymers company, recently announced its quarterly earnings report for the third quarter of 2021. The news sent ripples through the financial world, as the company’s earnings per share (EPS) came in lower than anticipated, missing the…

Read More